NCT02762500 - An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis | Biotech Hunter

Enrollment

124

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions

Colitis, Ulcerative

Interventions

DRUG

LYC-30937-EC

DRUG

Placebo

Trial Locations (71)

1088

Lycera Investigational Site, Budapest

1125

Lycera Investigational Site, Budapest

3000

Lycera Investigational Site, Hatvan

4031

Lycera Investigational Site, Debrecen

4032

Lycera Investigational Site, Debrecen

10024

Lycera Investigational Site, New York

10461

Lycera Investigational Site, The Bronx

11000

Lycera Investigational Site, Belgrade

11080

Lycera Investigational Site, Belgrade

11230

Lycera Investigational Site, Brooklyn

18000

Lycera Investigational Site, Niš

18840

Lycera Investigational Site, Sayre

19031

Lycera Investigational Site, Flourtown

19104

Lycera Investigational Site, Philadelphia

23000

Lycera Investigational Site, Zrenjanin

24000

Lycera Investigational Site, Subotica

27834

Lycera Investigational Site, Greenville

30033

Lycera Investigational Site, Decatur

30060

Lycera Investigational Site, Marietta

33021

Lycera Investigational Site, Hollywood

33176

Lycera Investigational Site, Miami

34000

Lycera Investigational Site, Kragujevac

37212

Lycera Investigational Site, Nashville

38261

Lycera Investigational Site, Union City

40202

Lycera Investigational Site, Louisville

48109

Lycera Investigational Site, Ann Arbor

60637

Lycera Investigational Site, Chicago

70809

Lycera Investigational Site, Baton Rouge

72212

Lycera Investigational Site, Little Rock

76092

Lycera Investigational Site., Houston

77004

Lycera Investigational Sites, Houston

Lycera Investigational Site, Houston

77030

Lycera Investigational Site, Houston

78229

Lycera Investigational Site, San Antonio

90822

Lycera Investigational Site, Long Beach

91345

Lycera Investigational Site, Mission Hills

92377

Lycera Investigational Site, Rialto

V8V 3M9

Lycera Investigational Site, Victoria

M5G 1X5

Lycera Investigational Site, Toronto

722 00

Lycera Investigational Site, Ostrava

130 00

Lycera Investigational Site, Prague

274 01

Lycera Investigational Site, Slaný

401 13

Lycera Investigational Site, Ústí nad Labem

1081 HZ

Lycera Investigational Site, Amsterdam

3015 CE

Lycera Investigational Site, Rotterdam

85-168

Lycera Investigational Site, Bydgoszcz

85-681

Lycera Investigational Site, Bydgoszcz

40-211

Lycera Investigational Site, Katowice

40-659

Lycera Investigational Site, Katowice

40-752

Lycera Investigational Site, Katowice

25 364

Lycera Investigational Site, Kielce

30-415

Lycera Investigational Site, Krakow

31-009

Lycera Investigational Site, Krakow

95-054

Lycera Investigational Site, Ksawerów

93-034

Lycera Investigational Site, Lodz

20-008

Lycera Investigational Site, Lublin

20-362

Lycera Investigational Site, Lublin

67-100

Lycera Investigational Site, Nowa Sól

05-500

Lycera Investigational Site, Piaseczno

61-113

Lycera Investigational Site, Poznan

96-100

Lycera Investigational Site, Skierniewice

81-756

Lycera Investigational Site, Sopot

28-200

Lycera Investigational Site, Staszów

71-270

Lycera Investigational Site, Szczecin

02-507

Lycera Investigational Site, Warsaw

04-749

Lycera Investigational Site, Warsaw

50-053

Lycera Investigational Site, Wroclaw

50-449

Lycera Investigational Site, Wroclaw

53-333

Lycera Investigational Site, Wroclaw

54-144

Lycera Investigational Site, Wroclaw

87-800

Lycera Investigational Site, Włocławek

All Listed Sponsors

lead

Lycera Corp.

INDUSTRY